{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:04:43Z","timestamp":1780319083291,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Substance use disorders (SUDs) remain a major source of preventable morbidity and mortality in the United States. This study described trends in the burden of SUDs from 1990 to 2019 by substance, sex, and age, and examined whether state-level policy environments and behavioral health budgets differed across states with the highest and lowest SUD-related disability-adjusted life years (DALYs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a descriptive epidemiologic study using Global Burden of Disease Study 2019 estimates for alcohol, opioid, cocaine, amphetamine, cannabis, and other drug use disorders in the United States. DALYs were the primary outcome and were examined by sex, age, substance, and year. To contextualize state-level disparities, we descriptively summarized behavioral health budget allocations and selected policy domains in states with the three highest and three lowest DALY rates for drug use disorders and alcohol use disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2019, prevalent SUD cases in the United States increased from 12.6\u00a0million to 19.5\u00a0million, and the age-standardized DALY rate for SUDs rose from 725.5 to 2,274.4 per 100,000 population. Opioid use disorders showed the largest increases in both prevalence (618.5%) and DALY rates (643.7%), becoming the leading contributor to SUD-related burden. Cocaine and amphetamine use disorders showed smaller increases in prevalence but larger increases in DALY rates, whereas alcohol use disorder changed modestly and cannabis-related DALY rates remained unchanged. In 2019, the age-standardized DALY rate for SUDs was higher among males than females (2,486.8 vs. 1,722.6 per 100,000 population). Opioid-related DALYs peaked in early adulthood, whereas alcohol-related DALYs peaked in midlife. Substantial geographic variation was observed: drug-related DALY rates were highest in West Virginia, Kentucky, and Ohio and lowest in Nebraska, South Dakota, and North Dakota, while alcohol-related DALY rates were highest in New Mexico, Alaska, and the District of Columbia and lowest in New Jersey, Maryland, and Texas. States with lower burden generally reflected more prevention-oriented and coordinated policy environments, although the presence of policy alone did not consistently correspond to lower burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The burden of SUDs in the United States increased substantially over three decades, driven primarily by opioids and with marked variation across sex, age, and geography. Descriptive comparisons suggest that policy context and behavioral health investment may help shape state-level differences, but implementation, treatment access, and broader structural conditions also matter. Coordinated, equitable, and adequately resourced prevention, treatment, and harm-reduction strategies are needed to reduce persistent disparities in SUD-related outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12963-026-00476-3","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:23:22Z","timestamp":1776659002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The changing landscape of substance use disorders over 30 years: insights on US state disparities and policy from the global burden of disease study"],"prefix":"10.1186","volume":"24","author":[{"given":"Shahrzad","family":"Bazargan-Hejazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Ahadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misagh","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaheed","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"476_CR1","first-page":"112","volume":"128","author":"AT McLellan","year":"2017","unstructured":"McLellan AT. Substance misuse and substance use disorders: why do they matter in healthcare? Trans Am Clin Climatol Assoc. 2017;128:112\u201330.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"9","key":"476_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1360-0443.1994.tb02787.x","volume":"89","author":"J Morgenstern","year":"1994","unstructured":"Morgenstern J, Langenbucher J, Labouvie EW. The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction. 1994;89(9):1105\u201313.","journal-title":"Addiction"},{"issue":"8","key":"476_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","volume":"170","author":"DS Hasin","year":"2013","unstructured":"Hasin DS, O\u2019Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834\u201351.","journal-title":"Am J Psychiatry"},{"key":"476_CR4","unstructured":"APA. Substance Use Disorders. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC2013."},{"issue":"12","key":"476_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","volume":"5","author":"L Degenhardt","year":"2018","unstructured":"Degenhardt L, Charlson F, Ferrari A, Santomauro DF, Erskine H, Mantilla-Herrera A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987\u20131012.","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"476_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ADM.0000000000000512","volume":"13","author":"D Eddie","year":"2019","unstructured":"Eddie D, Greene MC, White WL, Kelly JF. Medical burden of disease among individuals in recovery from alcohol and other drug problems in the United States: findings from the National Recovery Survey. J Addict Med. 2019;13(5):385\u201395.","journal-title":"J Addict Med"},{"issue":"20","key":"476_CR7","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1001\/jama.2019.16932","volume":"322","author":"SH Woolf","year":"2019","unstructured":"Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959\u20132017. JAMA. 2019;322(20):1996\u20132016.","journal-title":"JAMA"},{"key":"476_CR8","volume-title":"Substance Use Disorder Treatment For People With Physical and Cognitive Disabilities","author":"Center for Substance Abuse Treatment","year":"1998","unstructured":"Center for Substance Abuse Treatment. Substance Use Disorder Treatment For People With Physical and Cognitive Disabilities. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1998."},{"issue":"6","key":"476_CR9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1377\/hlthaff.2016.0082","volume":"35","author":"H Whiteford","year":"2016","unstructured":"Whiteford H, Ferrari A, Degenhardt L. Global burden Of disease studies: implications for mental and substance use disorders. Health Aff. 2016;35(6):1114\u201320.","journal-title":"Health Aff"},{"issue":"4","key":"476_CR10","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jfda.2013.09.038","volume":"21","author":"DC Daley","year":"2013","unstructured":"Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21(4):S73\u20136.","journal-title":"J Food Drug Anal"},{"issue":"1","key":"476_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pop.2016.09.013","volume":"44","author":"AA Kowalchuk","year":"2017","unstructured":"Kowalchuk AA, Gonzalez SJ, Zoorob RJ. Substance use issues among the underserved: United States and international perspectives. Prim Care. 2017;44(1):113\u201325.","journal-title":"Prim Care"},{"issue":"2","key":"476_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/2589977511666190319162901","volume":"11","author":"F Shamsaei","year":"2019","unstructured":"Shamsaei F, Baanavi M, Hassanian ZM, Cheraghi F. The impact of addiction on family members mental health status. Curr Drug Res Rev. 2019;11(2):129\u201334.","journal-title":"Curr Drug Res Rev"},{"key":"476_CR13","unstructured":"Soper RG. Intimate Partner Violence and Co-Occurring Substance Abuse\/Addiction. The American Society of Addiction Medicine Magazine; 2014."},{"issue":"2","key":"476_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ADM.0b013e318166af74","volume":"2","author":"R Saitz","year":"2008","unstructured":"Saitz R, Larson MJ, Labelle C, Richardson J, Samet JH. The case for chronic disease management for addiction. J Addict Med. 2008;2(2):55\u201365.","journal-title":"J Addict Med"},{"issue":"1","key":"476_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1377\/hlthaff.2015.0618","volume":"35","author":"J Gryczynski","year":"2016","unstructured":"Gryczynski J, Schwartz RP, O\u2019Grady KE, Restivo L, Mitchell SG, Jaffe JH. Understanding Patterns Of High-Cost Health Care Use Across Different Substance User Groups. Health Aff (Millwood). 2016;35(1):12\u20139.","journal-title":"Health Aff (Millwood)"},{"key":"476_CR16","unstructured":"Office of Disease Prevention and Health Promotion. Substance Abuse 2020 [Available from: https:\/\/www.healthypeople.gov\/2020\/leading-health-indicators\/2020-lhi-topics\/Substance-Abuse#1"},{"key":"476_CR17","unstructured":"McCance-Katz E. The National Survey on Drug Use and Health: 2019. SAMHSA, Services USDoHaH; 2020."},{"issue":"7","key":"476_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00127-017-1398-5","volume":"52","author":"KS Kendler","year":"2017","unstructured":"Kendler KS, Ohlsson H, Sundquist K, Sundquist J. Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis. Soc Psychiatry Psychiatr Epidemiol. 2017;52(7):877\u201386.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"9859","key":"476_CR19","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224\u201360.","journal-title":"Lancet"},{"key":"476_CR20","unstructured":"Substance Abuse and Mental Health Services Administration; Office of the Surgeon General. Facing Addiction in America: The Surgeon General\u2019s Report on Alcohol, Drugs, and Health [Internet]. Services DoHaH, editor2016."},{"key":"476_CR21","unstructured":"Prevention CfDCa. 2018 annual surveillance report of drug-related risks and outcomes\u2014United States. Report. Atlanta (GA); 2018."},{"key":"476_CR22","unstructured":"SAMHSA. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health https:\/\/www.samhsa.gov\/data\/: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020. Report No.: HHS Publication No. PEP20-07-01-001, NSDUH Series H-55."},{"key":"476_CR23","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD; 2020."},{"key":"476_CR24","unstructured":"Laws SAMHSA. and Regulations 2020 [Available from: https:\/\/www.samhsa.gov\/about-us\/who-we-are\/laws-regulations"},{"key":"476_CR25","unstructured":"SAMHSA. 2018 National Survey on Drug Use and Health: Methodological summary and definitions. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019."},{"issue":"4","key":"476_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00127-019-01753-3","volume":"55","author":"K Kuussaari","year":"2020","unstructured":"Kuussaari K, Karjalainen K, Niemela S. Mental health problems among clients with substance use problems: a nationwide time-trend study. Soc Psychiatry Psychiatr Epidemiol. 2020;55(4):507\u201316.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"10","key":"476_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","volume":"113","author":"A Peacock","year":"2018","unstructured":"Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905\u201326.","journal-title":"Addiction"},{"key":"476_CR28","unstructured":"Healthy People. 2030. Drug and Alcohol Use 2021 [Available from: https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/drug-and-alcohol-use"},{"key":"476_CR29","unstructured":"Administration SAaMHS. Behavioral Health Barometer: United States Rockville, MD2020 [updated 2025-05-20. 55\u201368]. Available from: https:\/\/www.samhsa.gov\/data\/report\/behavioral-health-barometer-volume-6"},{"issue":"6","key":"476_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","volume":"179","author":"R Abouk","year":"2019","unstructured":"Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019;179(6):805\u201311.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"476_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.7326\/M17-3074","volume":"168","author":"DS Fink","year":"2018","unstructured":"Fink DS, Schleimer JP, Sarvet A, Grover KK, Delcher C, Castillo-Carniglia A, et al. Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review. Ann Intern Med. 2018;168(11):783\u201390.","journal-title":"Ann Intern Med"},{"key":"476_CR32","unstructured":"Phillips JK, Ford MA, Bonnie RJ. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. 2017."},{"key":"476_CR33","unstructured":"IHME, About GBD. 2019 [Available from: http:\/\/www.healthdata.org\/gbd\/about"},{"issue":"10258","key":"476_CR34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJL Murray","year":"2020","unstructured":"Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"issue":"5","key":"476_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"key":"476_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"V Feigin","year":"2015","unstructured":"Feigin V, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systemic analysis for the global burden of disease study 2015. Lancet Neurol. 2015;16:877\u201397.","journal-title":"Lancet Neurol"},{"key":"476_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-021-01081-8","volume":"16","author":"J Purtle","year":"2021","unstructured":"Purtle J, Nelson KL, Horwitz SMC, McKay MM, Hoagwood KE. Determinants of using children\u2019s mental health research in policymaking: variation by type of research use and phase of policy process. Implement Sci. 2021;16:1\u201315.","journal-title":"Implement Sci"},{"key":"476_CR38","unstructured":"Trust for America\u2019s Health. Pain in the Nation: The Drug, Alcohol and Suicide Crises and Need for a National Resilience Strategy 2021 [Available from: https:\/\/www.tfah.org\/report-details\/pain-in-the-nation\/"},{"key":"476_CR39","unstructured":"Segal LM, De Biasi A, Mueller JL, May K, Warren M. Pain in the Nation: The Drug. Alcohol, and Suicide Crises and the Need for a National Resilience Strategy; 2017."},{"key":"476_CR40","unstructured":"National Association of State Mental Health Program Directors. State Mental Health Agency (SMHA) revenues and expenditures report, fiscal year 2020. Alexandria, VA; 2021."},{"key":"476_CR41","unstructured":"Nebraska Unicameral Legislature. Nebraska Revised Statute 25\u2009\u2013\u200921,186 2020 [Available from: https:\/\/nebraskalegislature.gov\/laws\/statutes.php?statute=25-21,186"},{"key":"476_CR42","unstructured":"North Dakota Legislative Branch. Chapter 32\u2009\u2013\u200903.1: Good Samaritan Act 2020 [Available from: https:\/\/www.legis.nd.gov\/cencode\/t32c03-1.html"},{"key":"476_CR43","unstructured":"North Dakota Board of Medicine. Prescription Drug Monitoring Program 2020 [Available from: https:\/\/www.ndbom.org\/practitioners\/PDMP.asp"},{"key":"476_CR44","unstructured":"South Dakota Department of Health. PRESCRIPTION DRUG MONITORING PROGRAM 2020 [Available from: https:\/\/doh.sd.gov\/boards\/pharmacy\/PDMP\/"},{"key":"476_CR45","unstructured":"National Conference of State Legislatures. Dram Shop Liability State Statutes 2013 [Available from: https:\/\/www.ncsl.org\/research\/financial-services-and-commerce\/dram-shop-liability-state-statutes.aspx"},{"key":"476_CR46","unstructured":"Alcohol Policy Information System. Prohibitions Against Hosting Underage Drinking Parties 2020 [Available from: https:\/\/alcoholpolicy.niaaa.nih.gov\/apis-policy-topics\/prohibitions-against-hosting-underage-drinking-parties\/41\/about-this-policy#page-content"},{"issue":"2","key":"476_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","volume":"33","author":"SF Greenfield","year":"2010","unstructured":"Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339\u201355.","journal-title":"Psychiatr Clin North Am"},{"key":"476_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/SAR.S183252","volume":"10","author":"KA Crapanzano","year":"2018","unstructured":"Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2018;10:1\u201312.","journal-title":"Subst Abuse Rehabil"},{"issue":"1\u20132","key":"476_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jnr.23963","volume":"95","author":"JB Becker","year":"2017","unstructured":"Becker JB, McClellan ML, Reed BG. Sex differences, gender and addiction. J Neurosci Res. 2017;95(1\u20132):136\u201347.","journal-title":"J Neurosci Res"},{"issue":"4","key":"476_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/YCO.0000000000000331","volume":"30","author":"R De Giorgi","year":"2017","unstructured":"De Giorgi R, D\u2019Alo GL, De Crescenzo F. Psychosocial interventions in stimulant use disorders: a focus on women. Curr Opin Psychiatry. 2017;30(4):275\u201382.","journal-title":"Curr Opin Psychiatry"},{"key":"476_CR51","unstructured":"CDC. Illicit Drug Use. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality; 2018."},{"key":"476_CR52","unstructured":"NIDA, Opioids. 2020 [Available from: https:\/\/www.drugabuse.gov\/drug-topics\/opioids"},{"key":"476_CR53","unstructured":"NIDA. Sex and Gender Differences in Substance Use. NIH; 2020."},{"issue":"6","key":"476_CR54","doi-asserted-by":"publisher","first-page":"853","DOI":"10.15288\/jsad.2017.78.853","volume":"78","author":"VL Forman-Hoffman","year":"2017","unstructured":"Forman-Hoffman VL, Edlund M, Glasheen C, Ridenour T. Alcohol initiation and progression to use, heavy episodic use, and alcohol use disorder among young adolescents ages 12\u201314 living in U.S. households. J Stud Alcohol Drugs. 2017;78(6):853\u201360.","journal-title":"J Stud Alcohol Drugs"},{"key":"476_CR55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2017.09.027","volume":"181","author":"L Giommoni","year":"2017","unstructured":"Giommoni L, Reuter P, Kilmer B. Exploring the perils of cross-national comparisons of drug prevalence: the effect of survey modality. Drug Alcohol Depend. 2017;181:194\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"476_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugpo.2018.10.005","volume":"63","author":"B Peteet","year":"2019","unstructured":"Peteet B, Mosley C, Miller-Roenigk B, McCuistian C, Dixon S. Transnational trends in prescription drug misuse among women: a systematic review. Int J Drug Policy. 2019;63:56\u201373.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"476_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2147\/SAR.S14898","volume":"2010","author":"LT Wu","year":"2010","unstructured":"Wu LT. Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse. Subst Abuse Rehabil. 2010;2010(1):5\u201311.","journal-title":"Subst Abuse Rehabil"},{"issue":"5\u20136","key":"476_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.lfs.2010.06.002","volume":"87","author":"AF Ceylan-Isik","year":"2010","unstructured":"Ceylan-Isik AF, McBride SM, Ren J. Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication? Life Sci. 2010;87(5\u20136):133\u20138.","journal-title":"Life Sci"},{"key":"476_CR59","first-page":"449","volume":"9","author":"M Arain","year":"2013","unstructured":"Arain M, Haque M, Johal L, Mathur P, Nel W, Rais A, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449\u201361.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"476_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0079-6123(08)63053-8","volume":"87","author":"JM Fuster","year":"1991","unstructured":"Fuster JM. The prefrontal cortex and its relation to behavior. Prog Brain Res. 1991;87:201\u201311.","journal-title":"Prog Brain Res"},{"issue":"3","key":"476_CR61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2975\/35.3.2012.235.243","volume":"35","author":"AJ Sheidow","year":"2012","unstructured":"Sheidow AJ, McCart M, Zajac K, Davis M. Prevalence and impact of substance use among emerging adults with serious mental health conditions. Psychiatr Rehabil J. 2012;35(3):235\u201343.","journal-title":"Psychiatr Rehabil J"},{"issue":"5","key":"476_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/0706743718792189","volume":"64","author":"RA Qadeer","year":"2019","unstructured":"Qadeer RA, Georgiades K, Boyle MH, Ferro MA. An epidemiological study of substance use disorders among emerging and young adults. Can J Psychiatry. 2019;64(5):313\u201322.","journal-title":"Can J Psychiatry"},{"issue":"4","key":"476_CR63","first-page":"PCC11r01320","volume":"14","author":"MH Taylor","year":"2012","unstructured":"Taylor MH, Grossberg GT. The growing problem of illicit substance abuse in the elderly: a review. Prim Care Companion CNS Disord. 2012;14(4):PCC11r01320.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"476_CR64","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12913-017-2538-z","volume":"17","author":"S Chhatre","year":"2017","unstructured":"Chhatre S, Cook R, Mallik E, Jayadevappa R. Trends in substance use admissions among older adults. BMC Health Serv Res. 2017;17(1):584.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"476_CR65","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","volume":"74","author":"BF Grant","year":"2017","unstructured":"Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001\u20132002 to 2012\u20132013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74(9):911\u201323.","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"476_CR66","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","volume":"5","author":"L Degenhardt","year":"2018","unstructured":"Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987\u20131012.","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"476_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF03391702","volume":"35","author":"MT Schulte","year":"2014","unstructured":"Schulte MT, Hser Y-I. Substance use and associated health conditions throughout the lifespan. Public Health Rev. 2014;35(2):1\u201327. https:\/\/doi.org\/10.1007\/BF03391702.","journal-title":"Public Health Rev"},{"key":"476_CR68","unstructured":"Healthy People 2030. Addiction 2020 [Available from: https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/addiction"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12963-026-00476-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:02:48Z","timestamp":1780315368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12963-026-00476-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s12963-026-00476-3","relation":{},"ISSN":["1478-7954"],"issn-type":[{"value":"1478-7954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require institutional review board approval or patient consent because no patient data was collected. We used publicly available national data (\n                      \n                      ). However, all methods were carried out in accordance with relevant guidelines and regulations (e.g. Helsinki declaration).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}